February 26, 2026
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
February 26, 2026
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
February 19, 2026
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
February 18, 2026
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
February 5, 2026